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Abstract
Objective To evaluate the associations of dietary fiber after myocardial
infarction (MI) and changes in dietary fiber intake from before to after
MI with all cause and cardiovascular mortality.
Design Prospective cohort study.
Setting Two large prospective cohort studies of US women and men
with repeated dietary measurements: the Nurses’ Health Study and the
Health Professionals Follow-Up Study.
Participants 2258 women and 1840 men who were free of
cardiovascular disease, stroke, or cancer at enrollment, survived a first
MI during follow-up, were free of stroke at the time of initial onset of MI,
and provided food frequency questionnaires pre-MI and at least one
post-MI.
Main outcome measures Associations of dietary fiber post-MI and
changes from before to after MI with all cause and cardiovascular
mortality using Cox proportional hazards models, adjusting for drug use,
medical history, and lifestyle factors.
Results Higher post-MI fiber intake was significantly associated with
lower all cause mortality (comparing extreme fifths, pooled hazard ratio
0.75, 95% confidence interval 0.58 to 0.97). Greater intake of cereal
fiber was more strongly associated with all cause mortality (pooled hazard
ratio 0.73, 0.58 to 0.91) than were other sources of dietary fiber.
Increased fiber intake from before to after MI was significantly associated
with lower all cause mortality (pooled hazard ratio 0.69, 0.55 to 0.87).
Conclusions In this prospective study of patients who survived MI, a
greater intake of dietary fiber after MI, especially cereal fiber, was
inversely associated with all cause mortality. In addition, increasing
consumption of fiber from before to after MI was significantly associated
with lower all cause and cardiovascular mortality.
Introduction
Diet plays an important role in the etiology of atherosclerosis
andcoronaryheartdisease,
1yetsecondarypreventionguidelines
generally emphasize pharmaceutical management owing to the
lack of evidence to guide diet and lifestyle recommendations.
2-8
The need for better lifestyle guidelines for survivors of
myocardial infarction (MI) is profound especially because a
substantialdropinthecasefatalityratehasincreasedthenumber
of survivors in the United States.
9 Compared with the general
population, this growing patient population is at higher risk for
mortality and may be more motivated to change their lifestyle
habits. Evidence as to whether and to what extent dietary
changesfrombeforetoafterMIimproveprognosisis,however,
insufficient.
Greater intake of dietary fiber improves glycemic response and
insulin sensitivity, increases the production of short chain fatty
acids, and increases satiety to help control overall energy
intake.
10 11 Dietary fiber is inversely associated with risk of
dyslipidemia,hypertension,obesity,diabetes,peripheralvascular
disease, coronary heart disease, and stroke.
12-17
The Diet and Reinfarction Trial (DART), the only clinical trial
of dietary fiber intake among 2033 male survivors of MI, did
notshowalowerrateofcoronaryandtotaldeathswithincreased
fiberintakeduringtwoyearsoffollow-upafterMI.
18 19However,
the study was limited by the short duration of follow-up, poor
compliance to the dietary intervention, and generalizability of
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Research
RESEARCHthe patient population. The DART trial was also conducted
almost 30 years ago. With more sensitive diagnostic criteria for
onset of MI and greater advances in clinical management, the
population of survivors of MI now differs from those at that
time. Thus, it is unknown what the long term impact of diet and
lifestyle change may have in a contemporary post-MI
population.
The Nurses’ Health Study (NHS) and the Health Professional
Follow-up Study (HPFS) are two large prospective cohort
studies of US women and men with repeated dietary
measurements both before and after MI. Using data from these
twocohorts,weevaluatedtheassociationofdietaryfiberintake
during the post-MI period, pre-MI period, and changes from
before to after MI on survival.
Methods
Study population
The Nurses’ Health Study is a prospective cohort of 121 700
US registered female nurses, aged 30-55 years in 1976. The
Health Professional Follow-up Study is a prospective cohort of
51529USmalehealthprofessionals,aged40-75yearsin1986.
In both studies the participants received detailed biennial
questionnaires on lifestyle and medical history.
We assessed diet and lifestyle characteristics among 2639
women and 2081 men who were free of cardiovascular disease,
stroke, or cancer at enrollment (1976 for women and 1986 for
men), survived a first MI during the follow-up through 2008,
and were free of stroke at the time of initial onset of MI. The
pre-MI period was defined as the time between the study
enrollment and the return of the last food frequency
questionnaire before the onset of MI. The post-MI period was
the time from the date of the first food frequency questionnaire
(FFQ) returned after the initial onset of MI until death or the
end of the study period, whichever occurred first.
Fromtheincidentnon-fatalMIevents,werestrictedouranalysis
toparticipantswhoprovidedbothpre-MIexposureinformation
and at least one post-MI food frequency questionnaire (2258
for women and 1840 for men). We excluded participants (381
forwomenand241formen;seesupplementarytable)whodied
before the return of the first post-MI food frequency
questionnaire or whose post-MI dietary assessment was
incomplete.
Exposure assessment
Dietary habits were assessed with a validated food frequency
questionnaire every four years from 1976-2006 for the Nurses’
Health Study and from 1986-2006 for the Health Professionals
Follow-up Study. The food frequency questionnaire assesses
average food intake over the previous year. Consumption of
each food is based on a commonly used unit or portion size,
with nine possible response categories of intake frequency,
ranging from “never” to “6 or more times per day.” Each
category is assigned a weight representing the midpoint of that
category. Estimates from the food frequency questionnaire
adequately reflect long term average dietary fiber intake based
onseveralweeksofformaldietrecords(r=0.68fordietaryfiber,
r=0.79 for cold breakfast cereal, the major source of fiber in
these two populations).
20-22
WeobtainedthedietaryfibercontentoffoodsfromtheHarvard
foodcompositiondatabase,whichisacompilationofdatafrom
the United States Department of Agriculture, the published
literature, food manufacturers, and outside consultation with
experts. We calculated energy adjusted values for all nutrients
including fiber to estimate the composition of dietary fiber in
the diet, independent of the total quantity of food reported.
23
Identification of incident MI
After participants self reported an incident MI, we sent them a
computer generated personalized letter requesting permission
to access their medical records. For non-respondents (<5% of
all men and women reporting a non-fatal MI), a research nurse
telephoned them to obtain further details on their diagnosis and
to seek permission for their medical records to be reviewed.
Study physicians reviewed the records blinded to the
participants’ exposure status. Myocardial infarction was
confirmed according to symptoms plus either diagnostic
electrocardiographic changes or increased levels of cardiac
enzymes, including cardiac specific troponin.
24
Outcome assessment
Our primary outcomes were all cause and cardiovascular
mortality.Weidentifieddeathsoccurringafterthefirstnon-fatal
MIduringfollow-upfromvitalrecords,thenationaldeathindex,
and reports by the participant’s next of kin, or the postal
system.
25 Our outcome of cardiovascular mortality consisted of
fatal MI, fatal stroke, and coronary heart disease, which were
confirmed through a review of medical records or autopsy
reports with the permission of the next of kin.
Covariate assessment
Covariates were chosen a priori based on previous studies. We
considered dietary covariates, medication use, medical history,
and lifestyles factors. Covariates were assessed from the
questionnaireimmediatelyprecedingtheinitialonsetofMIand
updatedwitheachsubsequentquestionnairecycle.IntheHealth
Professionals Follow-up Study, we also considered detailed
clinical characteristics obtained through medical chart review,
including ST segment elevation MI (yes or no), site of initial
MI (anterior, inferior, and other), revascularization at the time
of MI (primary angioplasty or thrombolytic therapy, versus
none), left ventricular ejection fraction (≥40%, <40%, or
missing), initial creatinine levels (continuous), and heart failure
during hospital stay (yes or no).
We included known predictors of MI survival and potential
confounders that changed the β coefficient by at least 10%. In
thefinalmodel,covariatesnotincludedduetolimitedevidence
ofconfoundingwerefamilyhistoryofMI,hypercholesterolemia,
height, protein intake, polyunsaturated fat intake, multivitamin
use, glycemic index, site of MI, ST elevation, and initial
creatinine level.
Statistical analysis
We defined change of dietary fiber from before to after MI as
the absolute difference between energy adjusted fiber intake
from the first post-MI food frequency questionnaire and the
mostrecentpre-MIfoodfrequencyquestionnaire.Weconsidered
both simple updated and cumulative average of fiber intake as
described elsewhere
26 and presented simple updated analyses
because of similar results. For missing data in the exposure and
covariates,wecarriedforwardthevaluereportedintheprevious
post-MI questionnaire cycle.
We used a Cox proportional hazards model with time since
return of the first post-MI food frequency questionnaire as the
underlying time scale. Person months were calculated from the
date of the first food frequency questionnaire returned after
initialMIuntildeathortheendofstudyperiod,whichevercame
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RESEARCHfirst. We also evaluated the association between pre-MI fiber
intake with post-MI survival starting at the date of initial onset
of MI. The proportional hazards assumption was tested by
modelingmultiplicativeinteractiontermsbetweentimeandthe
primary exposure variable. For analyses of trends, we fit
medians of each fifth as a continuous variable.
To evaluate potential survivor bias related to the requirement
that each participant had to have at least one post-MI dietary
assessment, we estimated the probability of not being missing,
and then reweighted the study population by the inverse of this
probability.
27
Fortheassociationbetweenpost-MIdietaryfiberandmortality,
we tested for possible effect modification by body mass index
(<25 or ≥25 kg/m
2), physical activity level (highest two fifths
versus lowest three fifths), and glycemic load (thirds) using the
likelihoodratiotest.Becausepreviousstudiessuggestapotential
interactionbetweenfiberintakeandlipidloweringmedications,
28
we also explored interactions with aspirin use (yes, no) and use
oflipidloweringmedications(yes,no).Weperformedanalyses
in men and women separately and evaluated heterogeneity of
results using the Cochrane Q statistics.
29 To pool results across
the sexes, we used fixed effect models in the absence of
significant heterogeneity, and random effect models
otherwise.
30 31
Dietary habits pre-MI (habitual diet) might affect post-MI
survival. We tested the hypothesis of a “carry-over effect” of
the pre-MI diet on post-MI mortality, adjusting for covariates
fromtheperiodbeforeMI.Toexaminetheassociationbetween
changes in dietary fiber in the period from before to after MI
and survival, we also adjusted for changes in covariates during
thatperiod.Formodelswithmissingcovariates,wetestedthree
differentmethods(missingindicator,imputedwithmedian,and
assuming no change from before to after MI periods) with
similar results, and therefore we present only the results using
the missing indicator method. We also modeled fiber intake by
nine subgroups of pre-MI (thirds) and post-MI fiber intake
(thirds) and used the likelihood ratio test to examine the
interaction between pre-MI and post-MI intake.
To ensure that the food frequency questionnaire only reflected
post-MI intake, we conducted sensitivity analyses that only
included participants whose first post-MI food frequency
questionnaire was returned at least 12 months after initial MI.
We additionally adjusted for β blocker use during the post-MI
period. Because lack of physical activity may indicate frailty
and severity of diseases, we also performed further sensitivity
analyses adjusting for physical activity with a two year lag or
excluding participants in the lowest fifth of physical activity.
We performed all statistical analyses using the Statistical
Analysis System 9.2 (SAS Institute).
Results
During 32 years of follow-up in women and 22 years in men,
we documented 2258 women and 1840 men with incident MI
and dietary assessments both before and after MI. Table 1⇓
summarizes the age standardized baseline characteristics of the
study population by fifths of energy adjusted fiber intake, with
baseline defined as the first questionnaire cycle post-MI.
The median follow-up post-MI was 8.7 years for women and
9.0yearsformen.Duringthefollow-up,weconfirmed682total
and 336 cardiovascular deaths for women, and 451 total and
222 cardiovascular deaths for men.
Higher post-MI fiber intake was significantly associated with
lower all cause mortality in age adjusted models for both men
and women (table 2⇓). Further adjustment for lifestyle
characteristicsanddietaryfactorsattenuatedtheseassociations,
butthepooledhazardratioremainedsignificantlyinverse(table
2).Whenwemodeledfiberasacontinuousvariable,thepooled
hazard ratio was 0.85 (95% confidence interval 0.74 to 0.97)
fortotalmortalityfora10g/dayincrementinintake.Ourresults
weresimilarafterusinginverseprobabilityweightingtoaccount
for potential selection bias (comparing extreme fifths, pooled
hazard ratio 0.89, 0.74 to 1.07, P for heterogeneity=0.13).
Further adjustment for pre-MI diet did not substantially alter
associations for post-MI diet.
To evaluate whether the association differed by fiber type, we
jointly examined cereal fiber, fruit fiber, and vegetable fiber.
Only intake of cereal fiber was strongly inversely associated
withlowerallcauseandcardiovascularmortality:pooledhazard
ratio 0.73 (0.58 to 0.91) for all cause mortality, 0.72 (0.52 to
0.99) for cardiovascular mortality (figure⇓).
Nosignificanteffectmodificationbybodymassindex,physical
activity level, glycemic load, aspirin or lipid lowering
medication use was observed. Results were also similar after
excluding participants with food frequency questionnaires
returned within 12 months of initial onset of MI, excluding
participants in the lowest fifth of physical activity, using a two
year lag for physical activity or additionally adjusting for β
blocker use (data not shown).
Pre-MI dietary fiber was not associated with post-MI mortality
(highest fifth versus lowest fifth, pooled hazard ratio 1.17, 0.92
to 1.48 for all cause mortality and 1.10, 0.77 to 1.55 for
cardiovascular mortality).
We also examined associations for change in fiber intake from
before to after MI. Participants on average increased their fiber
intake from the before to after MI period (table 3⇓). Spearman
correlationsforfiberintakebetweenpre-MIandthefirstpost-MI
were 0.48 for women and 0.53 for men. A greater increase in
fiber intake was significantly associated with lower all cause
and cardiovascular mortality in both sexes. Compared with
participants who were in the lowest third of fiber intake in both
pre-MI and post-MI periods, participants in the highest third in
both periods had the lowest all cause mortality: hazard ratio
0.73 (95% confidence interval 0.54 to 0.99), P for
interaction=0.01 for women, and 0.81 (0.58 to 1.13), P for
interaction=0.16 for men.
Discussion
In this prospective study of dietary intake after myocardial
infarction(MI),greaterintakeofdietaryfiber,especiallycereal
fiber, was inversely associated with all cause mortality.
Participants increased their average dietary fiber intake after
MI, and the greater the increase, the lower was the risk of
subsequent all cause and cardiovascular mortality. Overall, the
benefits for increased fiber intake were strongest for fiber from
cereal and grain sources.
Possible mechanisms for the beneficial effects of a high fiber
diet on coronary heart disease risk and mortality include
reductions in systemic inflammation, lower serum low density
lipoprotein cholesterol level, reduced lipid peroxidation,
improved insulin sensitivity, overall better glycemic control,
and a beneficial gut microbiota environment.
32-34 Many
biomarkers for these pathways have been studied in the
prediction of incident coronary heart disease, but few with the
exception of hyperlipidemia or inflammation have been
examined in patients post-MI.
35-40 It is likely that these
mechanisms would be similar in the post-MI environment, but
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RESEARCHmechanisms to explain lower overall mortality have not been
as thoroughly explored.
The benefits of fiber we observed were mainly from cereal and
grainsources.Inthegeneralpopulation,a20-40%riskreduction
incoronaryheartdiseasehasconsistentlybeenobservedamong
those who consume fiber-rich whole grains regularly,
13 yet less
than 5% of Americans consume the minimum recommended
fiber intake of 25 g/day for women and 38 g/day for men.
41 In
our study, the association with all cause mortality was stronger
than with cardiovascular mortality. This may occur because
patientswhohaveexperiencedMIareinitiallyandincreasingly
targeted for intensive medical and therapeutic management to
reduce their risk of recurrent cardiovascular events, and less so
for the many other causes of death. Because dietary fiber has
broad effects on other causes of death, our results may reflect
the success of secondary prevention in the past two decades.
Our results differ from the original DART trial, which is the
only existing study on dietary fiber in secondary prevention.
The DART trial showed that a high cereal fiber diet post-MI
did not reduce mortality among men only.
18 19 In that study,
2033 survivors of MI under age 70 (mean age 56.5 years) were
randomly assigned to dietary interventions that consisted of
counseling to consume either a low fat diet with a high
polyunsaturated to saturated fat ratio, a high fatty fish diet, or
a diet with a target of 18 g/day of cereal fiber and 30 g/day of
total dietary fiber.
19 After two years of follow-up, self reported
compliance was good, but no objective measure of fiber intake
was assessed.
18 Based on the reported average intake from
dietaryquestionnairesatsixmonths,only50%ofthepopulation
achieved the target of 18 g/day of cereal fiber,
18 19 and even
fewer reached the fiber target. Interestingly, when recontacted
approximately 10 years later, the 50% of DART participants
stillalivereportednoticeablyreducedintakeofcerealfiber(6.2
g/day in the intervention arm and 5.0 g/day in the control arm),
and there was no difference in mortality between the two
groups.
42Thusitislikelythatcompliancewasamajorchallenge
in this trial. Finally, participants were excluded at baseline if
theywerealreadyonahighcerealfiberdietorhadtheintention
to change to such a diet, leaving a study population of
participants less likely to comply. Thus, with short follow-up,
modest compliance, and a highly selective population, it is
difficult to generalize the null results from DART trial to our
free-living population with almost a decade of follow-up, a
broader age range, and no restraints on baseline diet at
enrollment. The PREDIMED (Prevencion con Dieta
Mediterranea) study provided convincing evidence for the
beneficial effects of the Mediterranean diet, high in
monounsaturated fats from nuts and extra virgin olive oil and
rich in fruits, vegetables, legumes, and non-refined grains, on
cardiovascular risk reduction.
43 44 Although it is not possible to
identify the specific aspects of the PREDIMED diets that
reduced cardiovascular disease, increasing fiber intake may
have contributed.
Limitations of this study
Our study has several limitations. Firstly, our food frequency
questionnaire is a reliable measure for assessing dietary intake
in the previous year,
20 45 46 but its validity is not known for
measuring intake within the same person before and after MI.
Thetimeintervalforthefoodfrequencyquestionnairescovering
the period between before and after MI could be up to eight
years. However, our results were similar after sensitivity
analyses excluding patients with missing information on the
first post-MI food frequency questionnaire.
Our results may be confounded by beneficial factors related to
fiber intake; foods that are high in fiber, such as whole grains,
fruits, and vegetables, also contain vitamins, minerals,
antioxidants,andphytochemicals,whichmayalsobebeneficial
forhealth.MedicationuseandseverityoftheinitialMIarealso
potential unmeasured confounders. Patients who consumed a
high fiber diet or changed to a high fiber diet after MI may also
have changed to many other healthy lifestyle factors post-MI,
which lowered subsequent mortality rates. We adjusted for
major confounders in our analyses, such as medication use,
other dietary factors, and physical activity using data from
questionnaires administered at the same time as the post-MI
food frequency questionnaire. Despite the adjustment in our
pooledanalysis,ahigherfiberdietpost-MIwasassociatedwith
long term reduced mortality. We also had a relatively
homogeneous population of health professionals, thus further
reducingpotentialresidualconfoundingbyunmeasuredfactors
associatedwithsocioeconomicstatus.Forchangesinfiberfrom
before MI to after MI analyses, we cannot fully adjust for all
known or unknown healthy lifestyle changes, and results may
stillbesubjecttomodestresidualandunmeasuredconfounding.
We conducted sensitivity analyses using medication
non-compliance as a potential unknown residual confounder
(see web extra appendix). We found that the relative risk was
only meaningfully attenuated in extreme conditions where the
association of medication non-compliance and fiber intake is
strong (40-45% difference in adherence prevalence) and where
the association with non-compliance and mortality is strong
(relative risk 2-3). We believe this is unlikely to occur because
these strong associations would need to be independent of
knowncovariatesalreadyinourmodel.Unfortunately,fewlarge
studies of clinical populations include the detailed dietary
information necessary for confirmation of our findings.
This study was limited to participants who had at least one
before MI and one after MI food frequency questionnaire.
Participants who died before the return of the first post-MI
questionnaire or did not return a post-MI one were not included
in the study. This could introduce a selection bias by excluding
patients who may be least sensitive to the benefits of dietary
modification.Weusedtheinverseprobabilityweightingmethod
to assess the impact of this bias and found that the results were
essentially unchanged.
Even with two of the largest long term prospective cohorts of
post-MI, we still had limited power to examine cause specific
mortality. We also were not able to examine optimal timing for
change in diet or potential interactions between dietary fiber
and post-MI medications. Future research on lifestyle changes
post-MIshouldfocusonacombinationoflifestylechangesand
how they may further reduce mortality rates beyond what is
achievable by medical management alone.
Ouranalysesshouldbeviewedinthecontextofrecentconcerns
about unrealistic findings in nutritional epidemiology.
47
Randomized trials of specific dietary factors could be
problematic and are subject to serious difficulties and bias due
tonon-complianceandattritionandcanrarelytestallhypothesis
based research questions. As a result, our findings, in
conjunction with feeding studies, other observational data, and
thesuccessofnutritionalinterventionsinpost-MIcaresuggested
bytheLyonHeartStudy,providerobustevidenceofthebenefits
of fiber for the large population of survivors of MI.
Strengths of this study
The strengths of our study include the large sample size and
longdurationoffollow-upfromtwoprospectivecohortstudies,
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RESEARCHwith follow-up rates in excess of 90% in each two year cycle.
OurstudymeasureddietaryintakerepeatedlyinbothbeforeMI
and after MI periods to reduce measurement error, and used
validated lifestyle questionnaires to assess other important risk
factors for survival.
Conclusion
Greater intake of dietary fiber after MI, especially cereal fiber,
was inversely associated with all cause and cardiovascular
mortality. In addition, participants who increased their dietary
fiber intake after MI had lower long term rates of all cause and
cardiovascular mortality.
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RESEARCHTables
Table 1| Age standardized baseline characteristics of 2258 women in the Nurses’ Health Study and 1840 men in the Health Professional
Follow-up Study by fifths of fiber intake after initial myocardial infarction (MI). Values are percentages unless stated otherwise
Men Women Characteristics
Highest fifth Third fifth Lowest fifth Highest fifth Third fifth Lowest fifth
358 373 367 457 437 433 No of participants
37.0 (5.8) 24.4 (1.0) 16.0 (2.4) 28.7 (4.4) 19.2 (0.8) 12.4 (2.0) Mean (SD) post-MI fiber intake*
27.8 (8.3) 22.3 (5.6) 17.3 (4.9) 22.2 (6.6) 17.5 (4.6) 14.0 (4.6) Mean (SD) pre-MI fiber intake†
9.2 (9.0) 2.1 (5.6) −1.3 (4.6) 6.5 (6.7) 1.7 (4.5) −1.6 (4.5) Mean (SD) change from before to
after MI‡
66.1 (8.9) 66.1 (8.9) 65.8 (9.5) 65.1 (8.2) 64.9 (8.5) 64.5 (8.8) Mean (SD) age at diagnosis
(years)§
25.6 (3.7) 26.1 (3.6) 26.4 (3.7) 26.3 (5.2) 27.6 (6.2) 26.3 (5.4) Mean (SD) body mass index
(kg/m
2)
40.4 (35.0) 37.0 (54.0) 25.9 (33.6) 20.1 (20.8) 13.4(18.4) 9.4 (13.5) Mean (SD) physical activity (MET
h/wk)
Smoking status:
41 36 28 38 30 25 Never smoker
47 52 54 58 61 51 Former smoker
1 4 9 4 9 24 Current smoker
88 90 85 69 69 64 Married
15 13 13 24 27 19 Diabetes
50 58 59 70 74 67 High blood pressure
64 63 68 79 80 71 Increased cholesterol level
81 82 78 64 62 61 Aspirin use
50 57 48 55 50 42 Lipid lowering drug use
74 76 70 63 53 53 CABGS
Reproductive factors:
Not applicable Not applicable Not applicable 4 4 5 Premenopause
Not applicable Not applicable Not applicable 28 29 29 Past PMH user
Not applicable Not applicable Not applicable 64 57 57 Current PMH user
Dietary intake:
1925 (621) 1946 (646) 1878 (620) 1592 (518) 1637 (526) 1619 (538) Mean (SD) total energy (kcal/d)
6.1 (2.0) 8.8 (2.4) 10.8 (3.0) 7.0 (2.1) 9.2 (2.3) 11.1 (3.2) Mean (SD) saturated fat (% of
energy)
0.9 (0.6) 0.7 (0.3) 0.7 (0.5) 0.8 (0.4) 0.7 (0.3) 0.7 (0.3) Mean (SD) n-3 fatty acids (% of
energy)
0.9 (0.5) 1.5 (0.6) 1.8 (0.8) 1.0 (0.5) 1.5 (0.5) 1.8 (0.8) Mean (SD) trans fatty acid (% of
energy)
6.3 (10.3) 9.1 (12.3) 13.4 (17.1) 2.9 (5.4) 4.3 (9.1) 6.0 (12.8) Mean (SD) alcohol (g/d)
874 (449) 699 (331) 542 (318) 613 (294) 488 (262) 389 (229) Mean (SD) folate (μg/d)
11.2 (4.8) 7.8 (2.8) 5.3 (2.1) 8.4 (4.0) 5.9 (2.2) 4.0 (1.7) Mean (SD) cereal fiber (g/d)
11.4 (3.5) 5.1 (0.5) 1.8 (0.7) 8.7 (2.6) 4.0 (0.4) 1.3 (0.6) Mean (SD) fruit fiber (g/d)
5.3 (2.1) 1.7 (0.2) 0.4 (0.3) 3.4 (1.6) 1.0 (0.1) 0.2 (0.1) Mean (SD) legume fiber (g/d)
Clinical characteristics:
8 9 8 Not available Not available Not available Heart failure
36 34 34 Not available Not available Not available Received acute therapy during
hospital stay
45 48 39 Not available Not available Not available Anterior MI
43 40 42 Not available Not available Not available ST elevation MI
80 80 84 Not available Not available Not available Normal left ventricular ejection
fraction
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RESEARCHTable 1 (continued)
Men Women Characteristics
Highest fifth Third fifth Lowest fifth Highest fifth Third fifth Lowest fifth
Nutrients were energy adjusted.
MET=metabolic equivalent task; CABGS=coronary artery bypass surgery; PMH=postmenopausal hormone use.
*Baseline diet factors are taken from participant’s first post-MI food frequency questionnaire; Lifestyle factors are taken from corresponding questionnaire by date
of first post-MI food frequency questionnaire.
†Pre-MI diet is taken from participant’s most recent food frequency questionnaire before initial MI onset.
‡Change of diet from pre-MI to post-MI is calculated as change=(post-MI diet−pre-MI diet).
§Age is not age standardized.
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RESEARCHTable 2| Multivariate adjusted hazard ratios for all cause and cardiovascular mortality according to fiber intake after initial myocardial
infarction (MI)
P for trend
Fifths of fiber intake after MI
Continuous (per
10 g increment) Estimates Fifth (highest) Fourth Third Second First (lowest)
All cause mortality
Women (n=682):
— 27.40 22.33 19.12 16.54 12.95 — Median intake (g/day)
— 102/4214 134/4195 123/4171 150/4247 173/4183 — Cases/person year
<0.0001 0.50 (0.39 to 0.64) 0.74 (0.58 to 0.93) 0.67 (0.53 to 0.85) 0.85 (0.68 to 1.07) 1.00 0.65 (0.56 to 0.76) Basic model adjusted
hazard ratio (95% CI)*
0.07 0.71 (0.51 to 0.98) 0.98 (0.74 to 1.30) 0.80 (0.61 to 1.04) 0.94 (0.74 to 1.20) 1.00 0.82 (0.68 to 1.00) Multivariate adjusted
hazard ratio (95% CI)†
Men (n=451):
— 35.60 28.50 24.36 20.90 16.34 — Median intake
— 79/3212 83/3206 93/3229 92/3216 104/3206 — Cases/person year
0.0008 0.63 (0.47 to 0.86) 0.64 (0.48 to 0.87) 0.80 (0.60 to 1.07) 0.85 (0.64 to 1.13) 1.00 0.79 (0.68 to 0.91) Basic model adjusted
hazard ratio (95% CI)*
0.25 0.82 (0.54 to 1.25) 0.85 (0.59 to 1.23) 0.99 (0.71 to 1.38) 1.03 (0.75 to 1.42) 1.00 0.88 (0.72 to 1.07) Multivariate adjusted
hazard ratio (95% CI)†
0.03 0.75 (0.58 to 0.97)§ 0.93 (0.74 to 1.16) 0.87 (0.71 to 1.07) 0.97 (0.80 to 1.18) 1.00 0.85 (0.74 to
0.97)‡
Pooled multivariate
adjusted hazard ratio (95%
CI)
Cardiovascular mortality
Women (n=336):
— 27.40 22.33 19.12 16.54 12.95 — Median intake
— 48/4214 76/4195 56/4171 76/4247 80/4183 — Cases/person year
0.003 0.55 (0.38 to 0.79) 0.93 (0.67 to 1.28) 0.65 (0.46 to 0.93) 0.93 (0.67 to 1.28) 1.00 0.71 (0.58 to 0.88) Basic model adjusted
hazard ratio (95% CI)*
0.83 0.85 (0.54 to 1.35) 1.27 (0.86 to 1.88) 0.74 (0.50 to 1.10) 1.00 (0.70 to 1.42) 1.00 0.95 (0.71 to 1.25) Multivariate adjusted
hazard ratio (95% CI)†
Men (n=222):
— 35.60 28.50 24.36 20.90 16.34 — Median intake
— 41/3212 41/3206 47/3229 47/3216 46/3206 — Cases/person year
0.07 0.73 (0.47 to 1.12) 0.71 (0.46 to 1.10) 0.89 (0.58 to 1.35) 0.96 (0.63 to 1.46) 1.00 0.82 (0.67 to 1.00) Basic model adjusted
hazard ratio (95% CI)*
0.52 0.89 (0.49 to 1.61) 0.85 (0.49 to 1.45) 0.93 (0.57 to 1.52) 1.09 (0.68 to 1.73) 1.00 0.87 (0.66 to 1.16) Multivariate adjusted
hazard ratio (95% CI)†
0.46 0.87 (0.60 to
1.24)**
1.11 (0.81 to 1.52) 0.81 (0.60 to 1.10) 1.03 (0.78 to 1.37) 1.00 0.91 (0.75 to
1.11)¶
Pooled multivariate
adjusted hazard ratio (95%
CI)
*Adjusted for time since MI onset, age at diagnosis (continuous), and calendar year.
†Additionally adjusted for total caloric intake (fifths of kcal), physical activity (fifths of metabolic equivalents/week), aspirin use (yes or no), diabetes (yes or no),
high blood pressure (yes or no), use of lipid lowering drugs (yes or no), alcohol consumption (0 g/day; 0.1-9.9 g/day; 10-29.9 g/day; or ≥30 g/day), saturated fat
intake (fifths of % of total energy), n3 fatty acid intake (fifths of % of total energy), trans fatty acid intake (fifths of % of total energy), married (yes or no), body mass
index (<21; 21-22.9; 23-24.9; 25-27.4; 27.5-29.9; >30 kg/m
2), coronary artery bypass surgery (yes or no), folate intake (fifths of μg/day), and pre-MI intake (fifths).
For women, additionally adjusted for smoking (never or missing; former; current, 1-14 cigarettes/day; current, 15-24 cigarettes/day; or current, ≥25 cigarettes/day),
status for postmenopausal hormone use (premenopause; never user; current user; former user).
For men, additionally adjusted for smoking (never or missing; former; current, <15 cigarettes/day; or current, ≥15 cigarettes/day), heart failure (yes or no), left
ventricular ejection fraction (≥40%, <40%, or missing), and acute therapy during admission to hospital (angioplasty or thrombolytics, or none).
‡P=0.62 for heterogeneity.
§P=0.59 for heterogeneity.
¶P=0.66 for heterogeneity.
**P=0.90 for heterogeneity.
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RESEARCHTable 3| Multivariate adjusted hazard ratios for all cause and cardiovascular mortality according to changes of fiber intake from period
before to after myocardial infarction (MI)
P for trend
Fifths of changes of fiber intake from period before to after MI
Continuous(per
10 g increment) Estimates Fifth (highest) Fourth Third Second First (lowest)
All cause mortality
Women (n=682):
9.87 5.48 2.76 0.20 −3.85 Median change
124/4196 123/4196 120/4202 126/4209 189/4206 Cases/person year
<0.0001 0.58 (0.46 to 0.74) 0.61 (0.48 to 0.77) 0.61 (0.48 to 0.77) 0.66 (0.52 to 0.84) 1.00 0.69 (0.59 to 0.80) Basic model adjusted
hazard ratio (95% CI)*
0.005 0.64 (0.48 to 0.86) 0.65 (0.49 to 0.86) 0.72 (0.55 to 0.93) 0.69 (0.53 to 0.89) 1.00 0.73 (0.60 to 0.88) Multivariate adjusted
hazard ratio (95% CI)†
Men (n=451):
11.63 6.30 3.05 0.02 −4.90 Median change
79/3212 83/3206 93/3229 92/3216 104/3206 Cases/person year
0.04 0.77 (0.57 to 1.04) 0.83 (0.62 to 1.12) 0.95 (0.71 to 1.27) 1.01 (0.76 to 1.35) 1.00 0.84 (0.72 to 0.98) Basic model adjusted
hazard ratio (95% CI)*
0.11 0.76 (0.53 to 1.10) 0.86 (0.61 to 1.20) 0.88 (0.63 to 1.23) 0.97 (0.71 to 1.33) 1.00 0.82 (0.68 to 1.00) Multivariate adjusted
hazard ratio (95% CI)†
0.002 0.69 (0.55 to 0.87)§ 0.73 (0.58 to 0.90) 0.78 (0.63 to 0.96) 0.80 (0.65 to 0.97) 1.00 0.77 (0.68 to
0.90)‡
Pooled multivariate
adjusted hazard ratio
(95% CI)
Cardiovascular mortality
Women (n=336):
9.87 5.48 2.76 0.20 −3.85 Median change
61/4196 70/4196 59/4202 58/4209 88/4206 Cases/person year
0.001 0.54 (0.38 to 0.76) 0.63 (0.46 to 0.88) 0.59 (0.42 to 0.83) 0.59 (0.42 to 0.83) 1.00 0.72 (0.58 to 0.90) Basic model adjusted
hazard ratio (95% CI)*
0.09 0.65 (0.42 to 0.99) 0.68 (0.46 to 1.01) 0.69 (0.47 to 1.02) 0.62 (0.42 to 0.91) 1.00 0.83 (0.63 to 1.09) Multivariate adjusted
hazard ratio (95% CI)†
Men (n=222):
11.63 6.30 3.05 0.02 −4.90 Median change
41/3212 41/3206 47/3229 47/3216 46/3206 Cases/person year
0.06 0.75 (0.49 to 1.12) 0.68 (0.45 to 1.05) 0.80 (0.53 to 1.20) 0.98 (0.66 to 1.47) 1.00 0.79 (0.64 to 0.97) Basic model adjusted
hazard ratio (95% CI)*
0.04 0.65 (0.39 to 1.08) 0.59 (0.36 to 0.97) 0.66 (0.41 to 1.05) 0.91(0.58 to 1.41) 1.00 0.72 (0.54 to 0.94) Multivariate adjusted
hazard ratio (95% CI)†
0.01 0.65 (0.47 to 0.90)** 0.64 (0.47 to 0.87) 0.69 (0.51 to 0.93) 0.74 (0.55 to 0.98) 1.00 0.72 (0.61 to
0.84)¶
Pooled multivariate
adjusted hazard ratio
(95% CI)
*Adjusted for time since MI onset, age at diagnosis (continuous), and calendar year.
†Additionally adjusted for aspirin use (never, new, always), diabetes (no, new, always), high blood pressure (no, new, always), use of lipid lowering drugs (never,
new, always), married (never, always, not anymore), coronary artery bypass surgery (never, always, new), changes in smoking status (always never, always past,
always current 1-14 cigarettes/day post-MI period, always current ≥15 cigarettes/day post-MI period, quit smoking after MI 1-14 cigarettes/day pre-MI period, quit
smoking after MI ≥15 cigarettes/day pre-MI period), and pre-MI fiber intake (fifths).
For women, additionally adjusted for changes in total caloric intake (fifths of kcal), changes in physical activity (fifths of changes in metabolic equivalents/week),
changes in alcohol consumption (fifths of changes in g/day), changes in body mass index (fifths of changes in kg/m
2), changes in saturated fat intake(fifths of
changes in % of total energy), changes in n3 fatty acid intake (fifths of changes in % of total energy), changes in trans fatty acid intake (fifths of changes in % of
total energy), changes in folate intake (fifths of changes in μg/day), and status of postmenopausal hormone use (premenopause, never, current, former).
For men, additionally adjusted for: changes in total caloric intake (thirds of kcal), changes in physical activity (thirds of changes in metabolic equivalents/week),
changes in alcohol consumption (thirds of changes in g/day), changes in body mass index (thirds of changes in kg/m
2), changes in saturated fat intake (thirds of
changes in % of total energy), changes in n3 fatty acid intake (thirds of changes in % of total energy), changes in trans fatty acid intake (thirds of changes in % of
total energy), changes in folate intake (thirds of changes in μg/day), heart failure (yes or no), left ventricular ejection fraction (≥40%, <40%, or missing), and acute
therapy during admission to hospital (received angioplasty or thrombolytics, or none).
‡P=0.35 for heterogeneity.
§P=0.47 for heterogeneity.
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RESEARCHTable 3 (continued)
P for trend
Fifths of changes of fiber intake from period before to after MI
Continuous(per
10 g increment) Estimates Fifth (highest) Fourth Third Second First (lowest)
¶P=0.53 for heterogeneity.
**P=1.00 for heterogeneity.
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RESEARCHFigure
Pooled hazard ratios for all cause and cardiovascular mortality according to intake of fiber from cereal, fruits, and legumes
in post-MI period (highest fifth versus lowest fifth). See footnote to table 2 for all adjustment variables
No commercial reuse: See rights and reprints http://www.bmj.com/permissions Subscribe: http://www.bmj.com/subscribe
BMJ 2014;348:g2659 doi: 10.1136/bmj.g2659 (Published 29 April 2014) Page 12 of 12
RESEARCH